222 related articles for article (PubMed ID: 21314348)
1. Cardiva Catalyst II vascular access management device in percutaneous diagnostic and interventional procedures with same-day discharge (Catalyst II trial).
Kiesz RS; Wiernek BK; Wiernek SL; Merritt C; Ybarra T; Iwanski A; Buszman PP; Szymanski R; Martin JL; Buszman PE
J Endovasc Ther; 2011 Feb; 18(1):46-53. PubMed ID: 21314348
[TBL] [Abstract][Full Text] [Related]
2. Commentary: The Cardiva Catalyst II device: a catalyzer of patient safety or a boomerang for the endovascular specialist?
Rezq A; Biondi-Zoccai G; Sangiorgi G
J Endovasc Ther; 2011 Feb; 18(1):54-6. PubMed ID: 21314349
[No Abstract] [Full Text] [Related]
3. The use of the StarClose device for obtaining femoral artery hemostasis.
Rodriguez A; Katz SG
Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
[TBL] [Abstract][Full Text] [Related]
4. The StarClose vascular closure device in antegrade and retrograde punctures: a single-center experience.
Chiu AH; Coles SR; Tibballs J; Nadkarni S
J Endovasc Ther; 2010 Feb; 17(1):46-50. PubMed ID: 20199266
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of antegrade common femoral artery access closure using the Angio-Seal device: experience with 1889 interventions for critical limb ischemia in diabetic patients.
Lupattelli T; Tannouri F; Garaci FG; Papa G; Pangos M; Somalvico F; Caravaggi C; Faglia E
J Endovasc Ther; 2010 Jun; 17(3):366-75. PubMed ID: 20557177
[TBL] [Abstract][Full Text] [Related]
6. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
Wong SC; Bachinsky W; Cambier P; Stoler R; Aji J; Rogers JH; Hermiller J; Nair R; Hutman H; Wang H;
JACC Cardiovasc Interv; 2009 Aug; 2(8):785-93. PubMed ID: 19695549
[TBL] [Abstract][Full Text] [Related]
7. Suppose a Perclose.
Hamel WJ
Prog Cardiovasc Nurs; 1999; 14(4):136-42. PubMed ID: 10689725
[TBL] [Abstract][Full Text] [Related]
8. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization.
Doyle BJ; Godfrey MJ; Lennon RJ; Ryan JL; Bresnahan JF; Rihal CS; Ting HH
Catheter Cardiovasc Interv; 2007 Feb; 69(2):203-8. PubMed ID: 17195965
[TBL] [Abstract][Full Text] [Related]
9. Early ambulation after percutaneous femoral access with use of closure devices and hemostatic agents.
Engelbert TL; Scholten A; Thompson K; Spivack A; Kansal N
Ann Vasc Surg; 2010 May; 24(4):518-23. PubMed ID: 20451795
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the StarClose vascular closure system using 7-F and 8-F sheath sizes: a consecutive single-center analysis.
Branzan D; Sixt S; Rastan A; Schwarz T; Schwarzwälder U; Bürgelin K; Noory E; Beyersdorf F; Zeller T
J Endovasc Ther; 2009 Aug; 16(4):475-82. PubMed ID: 19702352
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the 6-F ExoSeal vascular closure device in antegrade femoral artery punctures.
Maxien D; Behrends B; Eberhardt KM; Saam T; Thieme SF; Reiser MF; Treitl M
J Endovasc Ther; 2012 Dec; 19(6):836-43. PubMed ID: 23210885
[TBL] [Abstract][Full Text] [Related]
12. Angioseal versus manual compression for haemostasis following peripheral vascular diagnostic and interventional procedures--a randomized controlled trial.
Upponi SS; Ganeshan AG; Warakaulle DR; Phillips-Hughes J; Boardman P; Uberoi R
Eur J Radiol; 2007 Feb; 61(2):332-4. PubMed ID: 17071040
[TBL] [Abstract][Full Text] [Related]
13. Influence of use of a vascular closure device on incidence and surgical management of access site complications after percutaneous interventions.
Klocker J; Gratl A; Chemelli A; Moes N; Goebel G; Fraedrich G
Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):230-5. PubMed ID: 21498092
[TBL] [Abstract][Full Text] [Related]
14. Experience with the Cardiva Boomerang Catalyst system in pediatric cardiac catheterization.
Seltzer S; Alejos JC; Levi DS
Catheter Cardiovasc Interv; 2009 Sep; 74(3):476-81. PubMed ID: 19360859
[TBL] [Abstract][Full Text] [Related]
15. Shutting the door after antegrade femoral arteriotomy: should you push, clip, tie, or plug?
Biondi-Zoccai GG; Sangiorgi G
J Endovasc Ther; 2010 Jun; 17(3):376-9. PubMed ID: 20557178
[No Abstract] [Full Text] [Related]
16. Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children.
Waragai T; Morgan G; Ralston T; Chaturvedi R; Lee KJ; Benson L
Catheter Cardiovasc Interv; 2011 Aug; 78(2):262-6. PubMed ID: 21538780
[TBL] [Abstract][Full Text] [Related]
17. The use of vascular closure devices outside the catheterization laboratory after neurointerventional procedures is safe and effective: evidence from a retrospective study.
Khatri R; Rostambeigi N; Hassan AE; Carlson B; Rodriguez GJ; Qureshi AI
J Endovasc Ther; 2012 Apr; 19(2):239-45. PubMed ID: 22545890
[TBL] [Abstract][Full Text] [Related]
18. William Tell's arrow and the entrapment of catheters by a vascular closure device.
Kern MJ
Catheter Cardiovasc Interv; 2011 Jan; 77(1):56-7. PubMed ID: 21181970
[No Abstract] [Full Text] [Related]
19. Comments regarding 'Influence of use of a vascular closure device on incidence and surgical management of access sites. Complications after percutaneous interventions'.
Dosluoglu HH
Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):236-7. PubMed ID: 21592825
[No Abstract] [Full Text] [Related]
20. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of Closer
Wong SC; Gammon R; Bachinsky W; O'Shaughnessy C; Leimbach W; Bernardo N; Cavros N; Jaff MR; Liu PY; Bergman G
Catheter Cardiovasc Interv; 2017 Nov; 90(5):798-805. PubMed ID: 28833996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
